menu
    • menu

    Company profile for DUSA Pharmaceuticals, Inc.

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    DUSA Pharmaceuticals, Inc.® is a fully integrated specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% photodynamic therapy (PDT) technology platform used in conjunction with it’s proprietary light source, the BLU-U® Blue Light Photodynamic Therapy Illuminator. LEVULAN KERASTICK in combination with the BLU-U is a...
    DUSA Pharmaceuticals, Inc.® is a fully integrated specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% photodynamic therapy (PDT) technology platform used in conjunction with it’s proprietary light source, the BLU-U® Blue Light Photodynamic Therapy Illuminator. LEVULAN KERASTICK in combination with the BLU-U is approved by the U.S. Food and Drug Administration for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp. Actinic Keratosis is the most frequently diagnosed skin disease by U.S. dermatologists. PDT is a two part process in which the target cells are made extremely sensitive to light and then exposed to blue light, which destroys the cells. The BLU-U, as a stand alone device, uses light to treat mild to moderate inflammatory acne. DUSA is based in Wilmington, MA.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    DUSA Pharmaceuticals, Inc.United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    25 Upton Drive Wilmington, MA 01887
    Telephone
    Telephone
    +1 (978) 657-7500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.levulanhcp.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sun Pharma arm settles case with Biofrontera, to get $22.5 million
    Sun Pharma arm settles case with Biofrontera, to get $22.5 million

    02 Dec 2021

    // EXPRESS PHARMA

    https://www.expresspharma.in/sun-pharma-arm-settles-case-with-biofrontera-to-get-22-5-million/

    EXPRESS PHARMA
    02 Dec 2021
    Share Share
    Sun Pharma's subsidiary files patent infringement suit against Biofrontera
    Sun Pharma's subsidiary files patent infringement suit against Biofrontera

    12 Jul 2018

    // Divya Rajagopal ECONOMIC TIMES

    https://health.economictimes.indiatimes.com/news/pharma/sun-pharmas-subsidiary-files-patent-infringement-suit-against-german-drug-maker-biofrontera/64954247

    Divya Rajagopal ECONOMIC TIMES
    12 Jul 2018
    Share Share
    Levulan (Aminolevulinic Acid): DUSA Pharmaceuticals v. Biofrontera
    Levulan (Aminolevulinic Acid): DUSA Pharmaceuticals v. Biofrontera

    23 Mar 2018

    // PATENT LITIGATION

    https://www.pharmacompass.com/pdf/news/levulan-aminolevulinic-acid-dusa-pharmaceuticals-v-biofrontera-1522040614.pdf

    PATENT LITIGATION
    23 Mar 2018
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search